vimarsana.com
Home
Live Updates
Enabling Biotech Genus Claims Defined Only by Function
Enabling Biotech Genus Claims Defined Only by Function
Enabling Biotech Genus Claims Defined Only by Function — A Nearly Impossible Goal — Baxalta Incorporated v. Genentech Inc. (Fed. Cir. Sept. 20, 2023) | Kilpatrick Townsend & Stockton LLP
In the aftermath of Amgen v. Sanofi, courts continue to invalidate genus claims for lacking enablement. Baxalta Incorporated v. Genentech Inc.2 shows that it is nearly impossible to...
Related Keywords
United States ,
Delaware ,
Yifan Mao ,
Theodoreg Brown ,
Baxalta Gmbh Balxalta ,
Kilpatrick Townsend Stockton ,
United States District Court ,
Amgen Inc ,
Court Reasoning ,
Genentech ,
Supreme Court ,
Baxalta Inc ,
Balxalta Inc ,
Baxalta Incorporated ,
Amgen ,
Genentech Inc ,
Baxalta Gmbh ,
United States Patent ,
Federal Circuit ,
Kilpatrick Townsend ,